Effects of systemic chlorogenic acid on random-pattern dorsal skin flap survival in diabetic rats

Biological and Pharmaceutical Bulletin

Volumn 37, Issue 3, 2014, Pages 361-370

  Bagdas, Deniz ^a   Cam Etoz, Betul ^a   Inan Ozturkoglu, Sevda ^a   Cinkilic, Nilufer ^a   Ozyigit, Musa Ozgur ^a   Gul, Zulfiye ^a   Isbil Buyukcoskun, Naciye ^a   Ozluk, Kasim ^a   Gurun, Mine Sibel ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Antioxidant; Chlorogenic acid; Diabetes; Dorsal skin flap; Flap survival; Oxidative stress

Indexed keywords

CHLOROGENIC ACID; GLUCOSE; GLUTATHIONE; MALONALDEHYDE; NITRIC OXIDE; STREPTOZOCIN; SUPEROXIDE DISMUTASE; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GRAFT PERFUSION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MICROANGIOGRAPHY; NONHUMAN; RAT; SKIN FLAP SURVIVAL; WEIGHT CHANGE; WISTAR RAT; WOUND HEALING;

ANIMALS; ANTIOXIDANTS; CAPILLARIES; CHLOROGENIC ACID; DERMATOLOGIC SURGICAL PROCEDURES; DIABETES MELLITUS, EXPERIMENTAL; GLUTATHIONE; MALE; MALONDIALDEHYDE; NITRIC OXIDE; PLANT EXTRACTS; RATS; RATS, WISTAR; REFERENCE VALUES; SKIN; SUPEROXIDE DISMUTASE; SURGICAL FLAPS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84897007061     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b13-00635     Document Type: Article

References (60)

1. Myers B. Understanding flap necrosis. Plast. Reconstr. Surg., 78, 813-814 (1986).
2. Sloan GM, Reinisch JF. Flap physiology and the prediction of flap viability. Hand Clin., 1, 609-619 (1985).
3. Wang WZ, Baynosa RC, Zamboni WA. Update on ischemia-reperfusion injury for the plastic surgeon: 2011. Plast. Reconstr. Surg., 128, 685e-692e (2011).
4. Carden DL, Granger DN. Pathophysiology of ischaemia-reperfusion injury. J. Pathol., 190, 255-266 (2000).
5. Brem H, Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes. J. Clin. Invest., 117, 1219-1222 (2007).
6. Suzuki S, Miyachi Y, Niwa Y, Isshiki N. Significance of reactive oxygen species in distal flap necrosis and its salvage with liposomal SOD. Br. J. Plast. Surg., 42, 559-564 (1989).
7. Özyazgan I, Tuncer A, Yazc C, Günay GK. Reactive oxygen species in experimental ischemic flow-through venous flaps and effects of antioxidants on reactive oxygen species and flap survival. Ann. Plast. Surg., 58, 661-666 (2007).
8. Khalil AA, Aziz FA, Hall JC. Reperfusion injury. Plast. Reconstr. Surg., 117, 1024-1033 (2006).
9. Suzuki S, Yoshioka N, Isshiki N, Hamanaka H, Miyachi Y. Involvement of reactive oxygen species in post-ischaemic flap necrosis and its prevention by antioxidants. Br. J. Plast. Surg., 44, 130-134 (1991).
10. Suzuki S, Matsushita Y, Isshiki N, Hamanaka H, Miyachi Y. Salvage of distal flap necrosis by topical superoxide dismutase. Ann. Plast. Surg., 27, 253-257 (1991).
11. Ashoori F, Suzuki S, Zhou JH, Isshiki N, Miyachi Y. Involvement of lipid peroxidation in necrosis of skin flaps and its suppression by ellagic acid. Plast. Reconstr. Surg., 94, 1027-1037 (1994).
12. van den Heuvel MG, Bast A, Haenen GR, Ambergen AW, Mermans JF, van der Hulst RR. The role of antioxidants in ischaemia-reperfusion in a human DIEP flap model. J. Plast. Reconstr. Aesthet. Surg., 65, 1706-1711 (2012).
13. Manson PN, Anthenelli RM, Im MJ, Bulkley GB, Hoopes JE. The role of oxygen-free radicals in ischemic tissue injury in island skin flaps. Ann. Surg., 198, 87-90 (1983).
14. Muneuchi G, Hossain A, Yamaguchi F, Ueno M, Tanaka Y, Suzuki S, Tokuda M. The rare sugar D-allose has a reducing effect against ischemia-reperfusion injury on the rat abdominal skin island flap model. J. Surg. Res., 183, 976-981 (2013).
15. Arató E, Kürthy M, Sínay L, Kasza G, Menyhei G, Hardi P, Masoud S, Ripp K, Szilágyi K, Takács I, Miklós Z, Bátor A, Lantos J, Kollár L, Roth E, Jancsó G. Effect of vitamin E on reperfusion injuries during reconstructive vascular operations on lower limbs. Clin. Hemorheol. Microcirc., 44, 125-136 (2010).
16. Aydogan H, Gurlek A, Parlakpinar H, Askar I, Bay-Karabulut A, Aydogan N, Fariz A, Acet A. Beneficial effects of caffeic acid phenethyl ester (CAPE) on the ischaemia-reperfusion injury in rat skin flaps. J. Plast. Reconstr. Aesthet. Surg., 60, 563-568 (2007).
17. Hsieh YH, Huang SS, Wei FC, Hung LM. Resveratrol attenuates ischemia-reperfusion-induced leukocyte-endothelial cell adhesive interactions and prolongs allograft survival across the MHC barrier. Circ. J., 71, 423-428 (2007).
18. Clifford MN. Chlorogenic acids and other cinnamates-nature, occurrence and dietary burden. J. Sci. Food Agric., 79, 362-372 (1999).
19. Cinkilic N, Cetintas SK, Zorlu T, Vatan O, Yilmaz D, Cavas T, Tunc S, Ozkan L, Bilaloglu R. Radioprotection by two phenolic compounds: chlorogenic and quinic acid, on X-ray induced DNA damage in human blood lymphocytes in vitro. Food Chem. Toxicol., 53, 359-363 (2013).
20. Bagdas D, Cinkilic N, Ozboluk HY, Ozyigit MO, Gurun MS. Antihyperalgesic activity of chlorogenic acid in experimental neuropathic pain. J. Nat. Med., 67, 698-704 (2013).
21. dos Santos MD, Almeida MC, Lopes NP, de Souza GE. Evaluation of the anti-inflammatory, analgesic and antipyretic activities of the natural polyphenol chlorogenic acid. Biol. Pharm. Bull., 29, 2236-2240 (2006).
22. Shimoyama AT, Santin JR, Machado ID, Oliveira e Silva AM, de Melo IL, Mancini-Filho J, Farsky SH. Antiulcerogenic activity of chlorogenic acid in different models of gastric ulcer. Naunyn Schmiedebergs Arch. Pharmacol., 386, 5-14 (2013).
23. Karthikesan K, Pari L, Menon VP. Combined treatment of tetrahydrocurcumin and chlorogenic acid exerts potential antihyperglycemic effect on streptozotocin-nicotinamide-induced diabetic rats. Gen. Physiol. Biophys., 29, 23-30 (2010).
24. Hunyadi A, Martins A, Hsieh TJ, Seres A, Zupkó I. Chlorogenic acid and rutin play a major role in the in vivo anti-diabetic activity of Morus alba leaf extract on type II diabetic rats. PLoS ONE, 7, e50619 (2012).
25. Oboh G, Agunloye OM, Akinyemi AJ, Ademiluyi AO, Adefegha SA. Comparative study on the inhibitory effect of caffeic and chlorogenic acids on key enzymes linked to Alzheimer's disease and some pro-oxidant induced oxidative stress in rats' brain-in vitro. Neurochem. Res., 38, 413-419 (2013).
26. Lee K, Lee JS, Jang HJ, Kim SM, Chang MS, Park SH, Kim KS, Bae J, Park JW, Lee B, Choi HY, Jeong CH, Bu Y. Chlorogenic acid ameliorates brain damage and edema by inhibiting matrix metalloproteinase-2 and -9 in a rat model of focal cerebral ischemia. Eur. J. Pharmacol., 689, 89-95 (2012).
27. Chen WC, Liou SS, Tzeng TF, Lee SL, Liu IM. Effect of topical application of chlorogenic Acid on excision wound healing in rats. Planta Med., 79, 616-621 (2013).
28. Azuma K, Ippoushi K, Nakayama M, Ito H, Higashio H, Terao J. Absorption of chlorogenic acid and caffeic acid in rats after oral administration. J. Agric. Food Chem., 48, 5496-5500 (2000).
29. Junod A, Lambert AE, Stauffacher W, Renold AE. Diabetogenic action of streptozotocin: relationship of dose to metabolic response. J. Clin. Invest., 48, 2129-2139 (1969).
30. McFarlane RM, DeYoung G, Henry RA. The design of a pedicle flap in the rat to study necrosis and its prevention. Plast. Reconstr. Surg., 35, 177-182 (1965).
31. Cam Etoz B, Isbil Buyukcoskun N, Etoz A, Ozluk K. Preventing flap necrosis with adrenomedullin and glucagon-like peptide-1. Wounds, 24, 29-35 (2012).
32. Isken T, Ozgentas HE, Gulkesen KH, Ciftcioglu A. A random-pattern skin-flap model in streptozotocin diabetic rats. Ann. Plast. Surg., 57, 323-329 (2006).
33. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J. Biol. Chem., 193, 265-275 (1951).
34. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem., 95, 351-358 (1979).
35. Ellman GL. Tissue sulfhydryl groups. Arch. Biochem. Biophys., 82, 70-77 (1959).
36. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin. Chem., 34, 497-500 (1988).
37. Griess P, Bemerkungen zu der Abhandlung der HH. Über einige Azoverbindungen. Ber. Dtsch. Chem. Ges., 12, 426-428 (1879).
38. Babovic S, Shin MS, Angel MF, Im MJ, Vander Kolk CA, Manson PN. Flap tolerance to ischaemia in streptozotocin-induced diabetes mellitus. Br. J. Plast. Surg., 47, 15-19 (1994).
39. Cheon YW, Tark KC, Kim YW. Better survival of random pattern skin flaps through the use of epigallocatechin gallate. Dermatol. Surg., 38, 1835-1842 (2012).
40. Yun N, Kang JW, Lee SM. Protective effects of chlorogenic acid against ischemia/reperfusion injury in rat liver: molecular evidence of its antioxidant and anti-inflammatory properties. J. Nutr. Biochem., 23, 1249-1255 (2012).
41. Karthikesan K, Pari L, Menon VP. Antihyperlipidemic effect of chlorogenic acid and tetrahydrocurcumin in rats subjected to diabetogenic agents. Chem. Biol. Interact., 188, 643-650 (2010).
42. Bilen BT, Kilinç H, Alaybeyoglu N, Celik M, Iraz M, Sezgin N, Gültek A. Effect of caffeic acid phenethyl ester on survival of axial pattern flaps in rats with ischaemia-reperfusion injuries. Scand. J. Plast. Reconstr. Surg. Hand Surg., 40, 73-78 (2006).
43. Serarslan G, Altuǧ E, Kontas T, Atik E, Avci G. Caffeic acid phenethyl ester accelerates cutaneous wound healing in a rat model and decreases oxidative stress. Clin. Exp. Dermatol., 32, 709-715 (2007).
44. Ozturk A, Firat C, Parlakpinar H, Bay-Karabulut A, Kirimlioglu H, Gurlek A. Beneficial effects of aminoguanidine on skin flap survival in diabetic rats. Exp. Diabetes Res., 2012, 721256 (2012).
45. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev., 43, 109-142 (1991).
46. Witte MB, Barbul A. Role of nitric oxide in wound repair. Am. J. Surg., 183, 406-412 (2002).
47. Schwentker A, Vodovotz Y, Weller R, Billiar T. Nitric oxide and wound repair: role of cytokines? Nitric Oxide, 7, 1-10 (2002).
48. Lee R-H, Efron D, Tantry U, Barbul A. Nitric oxide in the healing wound: a time-course study. J. Surg. Res., 101, 104-108 (2001).
49. Cals-Grierson MM, Ormerod A. Nitric oxide function on the skin. Nitric Oxide, 10, 179-193 (2004).
50. Krischel V, Bruch-Gerharz D, Suschek C, Kröncke KD, Ruzicka T, Kolb-Bachofen V. Biphasic effect of exogenous nitric oxide on proliferation and differentiation on skin derived keratinocytes but not fibroblasts. J. Invest. Dermatol., 111, 286-291 (1998).
51. Korhonen R, Lahti A, Kankaanranta H, Moilanen E. Nitric oxide production and signaling in inflammation. Curr. Drug Targets Inflamm. Allergy, 4, 471-479 (2005).
52. Um SC, Suzuki S, Toyokuni S, Kim BM, Tanaka T, Hiai H, Nishimura Y. Involvement of nitric oxide in survival of random pattern skin flap. Plast. Reconstr. Surg., 101, 785-792 (1998).
53. Gribbe O, Gustafsson LE, Wiklund NP. Transdermally administered nitric oxide by application of acidified nitrite increases blood flow in rat epigastric island skin flaps. Eur. J. Pharmacol., 578, 51-56 (2008).
54. Brem H, Kodra A, Golinko MS, Entero H, Stojadinovic O, Wang VM, Sheahan CM, Weinberg AD, Woo SL, Ehrlich HP, Tomic-Canic M. Mechanism of sustained release of vascular endothelial growth factor in accelerating experimental diabetic healing. J. Invest. Dermatol., 129, 2275-2287 (2009).
55. Lan CC, Wu CS, Huang SM, Wu IH, Chen GS. High-glucose environment enhanced oxidative stress and increased interleukin-8 secretion from keratinocytes: New insights on impaired diabetic wound healing. Diabetes, 62, 2530-2538 (2013).
56. Yan X, Zeng B, Chai Y, Luo C, Li X. Improvement of blood flow, expression of nitric oxide, and vascular endothelial growth factor by low-energy shockwave therapy in random-pattern skin flap model. Ann. Plast. Surg., 61, 646-653 (2008).
57. Yingxin G, Guoqian Y, Jiaquan L, Han X. Effects of natural and recombinant hirudin on VEGF expression and random skin flap survival in a venous congested rat model. Int. Surg., 98, 82-87 (2013).
58. Zhu BH, Zhan WH, Li ZR, Wang Z, He YL, Peng JS, Cai SR, Ma JP, Zhang CH. (-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis. World J. Gastroenterol., 13, 1162-1169 (2007).
59. Shin JY, Sohn J, Park KH. Chlorogenic acid decreases retinal vascular hyperpermeability in diabetic rat model. J. Korean Med. Sci., 28, 608-613 (2013).
60. Perrin RM, Konopatskaya O, Qiu Y, Harper S, Bates DO, Churchill AJ. Diabetic retinopathy is associated with a switch in splicing from anti- to pro-angiogenic isoforms of vascular endothelial growth factor. Diabetologia, 48, 2422-2427 (2005).